Aurora Spine
Private Company
Total funding raised: $15M
Overview
Aurora Spine is an emerging growth company in the spinal implant market, specializing in minimally invasive, screwless, and regenerative technologies. The company has a commercial portfolio including the DEXA Technology™, ZIP™, SiLO™, and AERO™ systems, and is actively launching new products like a biologics portfolio. With a patient-centric philosophy of matching implants to anatomy, Aurora is positioning itself as a disruptive player in a large and growing spine surgery market, as evidenced by its record quarterly financial results and increasing surgical procedure milestones.
Technology Platform
Focus on screwless, minimally invasive, and regenerative spinal implant technologies designed to match patient anatomy. Core platforms include DEXA Technology™ for interbody fusion and the SiLO™ system for SI joint fusion.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Aurora competes in the multi-billion dollar spinal implant market against giants like Medtronic, Stryker, NuVasive, and Johnson & Johnson's DePuy Synthes. Its competitive strategy is to avoid direct, head-to-head competition by focusing on niche, minimally invasive, and screwless technologies where larger players may be less agile.